Overview
Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Vasundhara Rasayans Limited engages in the manufacture and sale of antacids therapeutic category of active pharmaceutical ingredients (API) in India. It offers antacid API, such as aluminum hydroxide gel, magnesium hydroxide, magaldrate, magnesium trisilicate, magnesium silicate, and aluminum phosphate. The company also provides aluminum hydroxide gel with low heavy lead content for lake color; aluminum hydroxide amorphous, aluminum sulphate, and poly aluminum chloride for water treatment and aluminum salts applications; and organic API intermediate and dyes intermediate. In addition, it offers technical backup support services. The company serves pharmaceutical, food, and chemical industries. It also exports its products. The company was incorporated in 1987 and is based in Hyderabad, India. Vasundhara Rasayans Limited operates as a subsidiary of P&J Cretechem Private Limited.
Quarterly Results
Rs. Crores ยท hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
6.93
11.89
7.45
8.82
7.56
7.76
8.82
9.78
7.63
11.14
8.23
9.32
8.33
Expenses
6.24
9.05
6.94
6.70
7.23
7.75
7.25
8.16
6.77
8.87
6.77
7.62
7.36
Operating Profit
0.69
2.84
0.51
2.12
0.33
0.01
1.57
1.62
0.86
2.27
1.46
1.70
0.97
OPM %
9.96
23.89
6.85
24.04
4.37
0.13
17.80
16.56
11.27
20.38
17.74
18.24
11.64
Other Income
0.37
0.69
0.67
0.86
0.68
0.83
0.54
0.53
0.45
0.74
0.50
0.27
0.42
Depreciation
0.13
0.11
0.11
0.11
0.10
0.10
0.09
0.09
0.08
0.08
0.08
0.06
0.04
Interest
0.05
0.08
0.10
0.09
0.14
0.08
0.06
0.08
0.06
0.07
0.01
0.03
0.06
Profit before tax
0.88
3.34
0.97
2.78
0.77
0.66
1.96
1.98
1.17
2.86
1.87
1.88
1.29
Tax %
26.14
25.75
25.77
25.90
25.97
31.82
26.02
26.26
25.64
25.52
26.20
26.06
26.36
Net Profit
0.65
2.48
0.72
2.06
0.57
0.45
1.45
1.47
0.86
2.13
1.38
1.39
0.96
EPS in Rs
2.05
7.80
2.27
6.48
1.79
1.42
4.56
4.63
2.71
6.70
4.34
4.37
3.02
Profit & Loss
Annual ยท Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
35.72 33.99 36.96 37.88 26.70 22.68 21.17 19.71 16.58 15.41 15.27 18.40
Expenses
29.88 29.88 30.53 32.32 24.49 19.57 18.33 18.55 14.78 13.76 13.97 16.80
Operating Profit
5.84 4.11 6.43 5.56 2.21 3.11 2.84 1.16 1.80 1.65 1.30 1.60
OPM %
16.35 12.09 17.40 14.68 8.28 13.71 13.42 5.89 10.86 10.71 8.51 8.70
Other Income
2.90 2.35 1.94 2.30 1.04 0.99 1.15 1.04 7.74 0.44 0.25 0.31
Interest
0.45 0.34 0.21 0.25 0.09 0.09 0.06 0.08 0.17 0.39 0.57 0.53
Depreciation
0.43 0.36 0.26 0.13 0.12 0.05 0.03 0.05 0.32 0.56 0.56 0.50
Profit before tax
7.86 5.76 7.90 7.48 3.04 3.96 3.90 2.07 9.05 1.14 0.42 0.88
Tax %
26.46 26.39 25.82 25.27 28.62 25.76 23.59 29.95 28.07 59.65 45.24 34.09
Net Profit
5.79 4.25 5.86 5.59 2.17 2.94 2.99 1.45 6.52 0.46 0.24 0.58
EPS in Rs
18.22 13.37 18.44 17.59 6.83 9.25 9.41 4.56 20.51 1.45 0.76 1.82
Dividend Payout %
10.98 14.96 0.00 0.00 14.65 16.22 15.95 21.93 4.88 69.13 0.00 27.41
Balance Sheet
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
3.18 3.18 3.18 3.18 3.18 3.18 3.18 3.18 3.18 3.18 3.18 3.18
Reserves
37.70 32.38 28.76 23.64 18.36 16.69 14.23 11.63 10.56 4.04 3.96 3.72
Borrowings
1.81 4.21 1.95 4.02 1.31 0.00 0.00 0.46 1.41 3.10 5.01 5.58
Other Liabilities
5.19 3.30 3.41 3.68 2.66 3.14 7.28 5.56 5.23 3.13 3.21 4.16
Total Liabilities
47.88 43.07 37.30 34.52 25.51 23.01 24.69 20.83 20.38 13.45 15.36 16.64
Fixed Assets
2.35 2.49 2.43 0.86 0.91 0.67 0.30 0.20 0.10 6.78 7.28 7.62
CWIP
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments
2.51 2.35 1.16 0.00 0.32 1.12 0.97 1.23 1.10 0.07 0.18 0.23
Other Assets
43.02 38.23 33.71 33.66 24.28 21.22 23.42 19.40 19.18 6.60 7.90 8.79
Total Assets
47.88 43.07 37.30 34.52 25.51 23.01 24.69 20.83 20.38 13.45 15.36 16.64
Cash Flows
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
-1.58 -5.83 6.03 -6.50 7.90 0.22 0.36 0.43 -10.70 2.42 1.32 1.56
Cash from Investing Activity
2.01 0.46 -1.32 1.27 1.39 0.16 1.02 0.53 13.30 0.07 -0.06 -2.02
Cash from Financing Activity
-3.44 1.35 -2.88 2.19 0.79 -0.49 -0.87 -1.36 -2.26 -2.24 -1.28 0.46
Net Cash Flow
-3.01 -4.02 1.83 -3.04 10.08 -0.12 0.50 -0.41 0.33 0.24 -0.01 0.00
Free Cash Flow
-1.88 -6.25 4.20 -6.58 7.55 -0.20 0.23 0.29 3.34 2.38 1.10 -0.50
CFO/OP %
-13.00 -78.00 125.00 -95.00 397.00 51.00 36.00 153.00 -457.00 164.00 114.00 117.00
Ratios
Annual ยท Days / % โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
76.23 44.56 61.43 77.57 100.34 99.30 107.41 94.63 131.65 89.53 93.22 74.39
Inventory Days
36.74 44.33 38.86 79.48 57.91 48.01 59.00 60.51 64.32 69.11 53.90 45.71
Days Payable
67.68 42.91 40.43 48.68 57.65 76.61 59.39 45.28 62.28 52.91 31.68 59.78
Cash Conversion Cycle
45.29 45.98 59.85 108.36 100.60 70.70 107.02 109.85 133.69 105.73 115.44 60.32
Working Capital Days
344.26 274.47 193.76 174.50 127.82 143.88 267.41 245.56 258.67 14.69 12.43 11.90
ROCE %
20.16 16.56 25.06 28.79 12.92 21.73 23.75 14.14 14.21 13.44 8.04 12.04
Shareholding Pattern
% holding โ latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
61.98
61.98
61.98
61.98
61.98
61.98
61.98
61.98
61.98
61.98
61.98
61.98
Public
38.02
38.01
38.01
38.02
38.02
38.01
38.02
38.02
38.02
38.02
38.02
38.01
No. of Shareholders
5,977
6,006
6,080
6,237
6,328
6,323
6,330
6,175
5,627
5,395
5,510
5,575
Corporate Actions
8 records
Back to all stocks